AF Substrate Mapping and Guided Ablation

NACompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Persistent Atrial Fibrillation
Interventions
DEVICE

Substrate+mCPVA

The intervention in the experimental arm includes using a research software (investigational device) to map AF substrate and guide ablation.

DEVICE

mCPVA

The intervention in the active comparator arm includes using the commercially available EnSite Velocity mapping and ablation system for modified circumferential pulmonary vein ablation.

Trial Locations (1)

20097

I.R.C.C.S. Policlinico San Donato, San Donato Milanese

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT02571218 - AF Substrate Mapping and Guided Ablation | Biotech Hunter | Biotech Hunter